Lynx Biosciences

Lynx Biosciences, Inc. is a cell omics company focused on developing transformative therapies for blood cancers. By combining physiologically relevant suspension cell co-culture assays, automated microfluidic technology, and deep learning analysis, it aims to rapidly advance drug candidates in the oncology field and provide personalized cancer treatments for patients.